Efficacy and safety of cariprazine augmentation in patients treated with clozapine: a pilot study

BACKGROUND: Cariprazine, a novel antipsychotic drug, is a partial agonist of dopamine D2/D3 receptors with preferential binding to the D3 receptor. There has been an increasing interest in cariprazine augmentation to clozapine; however, the evidence thus far has been only limited to case reports and...

Descripción completa

Detalles Bibliográficos
Autores principales: Pappa, Sofia, Kalniunas, Arturas, Sharma, Hitendra, Raza-Syed, Ali, Kamal, Manzar, Larkin, Fintan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685211/
https://www.ncbi.nlm.nih.gov/pubmed/36439679
http://dx.doi.org/10.1177/20451253221132087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685211/
https://www.ncbi.nlm.nih.gov/pubmed/36439679
http://dx.doi.org/10.1177/20451253221132087

Ejemplares similares